Finance
Italy’s Angelini Said to Explore Catalyst Pharma Acquisition
Italian drugmaker Angelini Pharma is exploring a potential acquisition of Catalyst Pharmaceuticals Inc. as it looks at deals to expand its footprint globally, people familiar with the matter said.
B
Bloomberg
April 27, 2026·1 min read
Image: Bloomberg
Italian drugmaker Angelini Pharma is exploring a potential acquisition of Catalyst Pharmaceuticals Inc. as it looks at deals to expand its footprint globally, people familiar with the matter said.
Original article
Italy’s Angelini Said to Explore Catalyst Pharma Acquisition
Published by Bloomberg